The novel pyrimidine and purine derivatives of L-ascorbic acid:: synthesis, one- and two-dimensional 1H and 13C NMR study, cytostatic and antiviral evaluation

被引:38
作者
Gazivoda, T
Plevnik, M
Plavec, J
Kraljevic, S
Kralj, M
Pavelic, K
Balzarini, J
De Clercq, E
Mintas, M
Raci-Malic, S
机构
[1] Univ Zagreb, Fac Chem Engn & Technol, Dept Organ Chem, HR-10000 Zagreb, Croatia
[2] Natl Inst Chem, Slovenian NMR Ctr, SL-1001 Ljubljana, Slovenia
[3] Rudjer Boskovic Inst, Div Mol Med, HR-10001 Zagreb, Croatia
[4] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
pyrimidine and purine derivatives of L-ascorbic acid; E and Z isomers; cytostatic activity; antiviral activity apoptosis;
D O I
10.1016/j.bmc.2004.09.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The syntheses of the novel C-5 substituted pyrimidine derivatives Of L-ascorbic acid containing free hydroxy groups at C-2' (6-10) or C-2' and C-3' (11-15) positions of the lactone ring are described. Debenzylation of the 6-chloro- and 6-(N-pyrrolyl)purine derivatives of 2,3-O,O-dibenzyl-L-ascorbic acid (16 and 17) gave the new compounds containing hydroxy groups at C-2' (18) and C-2' and C-3' (19 and 20). Z- and E-configuration of the C4'=C5' double bond and position of the lactone ring of the compounds 6-9 were deduced from their one- and two-dimensional H-1 and C-13 NMR spectra and connectivities in NOESY and HMBC spectra. Compounds 15 and 18 showed the best inhibitory activities of all evaluated compounds in the series. The compound 15 containing 5-(trifluoromethyl)uracil showed marked inhibitory activity against all human malignant cell lines (IC50: 5.6-12.8 muM) except on human T-lymphocytes. Besides, this compound influenced the cell cycle by increasing the cell population in G2/M phase and induced apoptosis in SW 620 and MiaPaCa-2 cells. The compound 18 containing 6-chloropurine ring expressed the most pronounced inhibitory activities against HeLa (IC50: 6.8 muM) and MiaPaCa-2 cells (IC50: 6.5 muM). The compound 20 with 6-(N-pyrrolyl)purine moiety showed the best differential inhibitory effect against MCF-7 cells (IC50: 35.9 muM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 28 条
[21]   MOLECULAR TARGETS FOR AIDS THERAPY [J].
MITSUYA, H ;
YARCHOAN, R ;
BRODER, S .
SCIENCE, 1990, 249 (4976) :1533-1544
[22]   Synthesis of novel vitamin C phosphodiesters: Stability and antioxidant activity [J].
Morisaki, K ;
Ozaki, S .
CARBOHYDRATE RESEARCH, 1996, 286 :123-138
[23]   Novel pyrimidine and purine derivatives of L-ascorbic acid: Synthesis and biological evaluation [J].
Raic-Malic, S ;
Hergold-Brundic, A ;
Nagl, A ;
Grdisa, M ;
Pavelic, K ;
De Clercq, E ;
Mintas, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (14) :2673-2678
[24]   Synthesis and antitumor activities of novel pyrimidine derivatives of 2,3-O,O-dibenzyl-6-deoxy-L-ascorbic acid and 4,5-didehydro-5,6-dideoxy-L-ascorbic acid [J].
Raic-Malic, S ;
Svedruzic, D ;
Gazivoda, T ;
Marunovic, A ;
Hergold-Brundic, A ;
Nagl, A ;
Balzarini, J ;
De Clercq, E ;
Mintas, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4806-4811
[25]   Regio- and chemoselective alkylation of L-ascorbic acid under Mitsunobu conditions [J].
Tahir, H ;
Hindsgaul, O .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (03) :911-913
[26]  
WELCH RW, 1994, J BIOL CHEM, V269, P1041
[27]   Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-α-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants [J].
Yamamoto, I ;
Tai, A ;
Fujinami, Y ;
Sasaki, K ;
Okazaki, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :462-468
[28]  
Yamano Y, 1998, HETEROCYCLES, V47, P289